Edward Neuwelt

Professor

  • 14455 Citations
  • 62 h-Index
1971 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Blood-Brain Barrier Medicine & Life Sciences
Brain Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Brain Medicine & Life Sciences
Central Nervous System Medicine & Life Sciences
Ferrosoferric Oxide Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1976 2021

Blood-Brain Barrier
Antineoplastic Agents
Drug Therapy
Cisplatin
Neoplasms
Lung Neoplasms
Neoplasm Metastasis
temozolomide
Brain Neoplasms
Blood Volume
Nanoparticles
Magnetic Resonance Imaging
Inflammation
Ferrosoferric Oxide
Blood Vessels
Blood-Brain Barrier
Brain Neoplasms
Research Personnel
Research
Clinical Protocols

Research Output 1971 2019

  • 14455 Citations
  • 62 h-Index
  • 307 Article
  • 9 Chapter
  • 2 Review article
  • 1 Conference contribution

Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression

Barajas, R., Hamilton, B., Schwartz, D., Mcconnell, H. L., Pettersson, D., Horvath, A., Szidonya, L., Varallyay, C. G., Firkins, J., Jaboin, J., Kubicky, C. D., Raslan, A., Dogan, A., Cetas, J., Ciporen, J., Han, S. J., Ambady, P., Muldoon, L., Woltjer, R. R., Rooney, W. & 1 othersNeuwelt, E., Mar 18 2019, In : Neuro-Oncology. 21, 4, p. 517-526 10 p.

Research output: Contribution to journalArticle

Open Access
Ferrosoferric Oxide
Gadolinium
Glioblastoma
Nanoparticles
Isocitrate Dehydrogenase

Blood-Brain Barrier Disruption Chemotherapy

McGregor, J. M., Bell, S. D., Doolittle, N., Murillo, T. P. & Neuwelt, E., Apr 24 2018, Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy: Second Edition. Elsevier Inc., p. 145-153 9 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Blood-Brain Barrier
Drug Therapy
Central Nervous System
Oligodendroglioma
Brain Neoplasms
1 Citation (Scopus)

Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care

Varallyay, C. G., Nesbit, E., Horvath, A., Varallyay, P., Fu, R. R., Gahramanov, S., Muldoon, L., Li, X., Rooney, W. & Neuwelt, E., Jan 1 2018, (Accepted/In press) In : Journal of Magnetic Resonance Imaging.

Research output: Contribution to journalArticle

Ferrosoferric Oxide
Standard of Care
Perfusion
Noise
Putamen

Combination immunotherapy as a non-chemotherapy alternative for refractory or recurrent CNS lymphoma

Ambady, P., Szidonya, L., Firkins, J., James, J., Johansson, K., White, T., Jezierski, C., Doolittle, N. & Neuwelt, E., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Immunotherapy
Lymphoma
16 Citations (Scopus)

Sodium thiosulfate for protection from cisplatin-induced hearing loss

Brock, P. R., Maibach, R., Childs, M., Rajput, K., Roebuck, D., Sullivan, M. J., Laithier, V., Ronghe, M., Dall'Igna, P., Hiyama, E., Brichard, B., Skeen, J., Mateos, M. E., Capra, M., Rangaswami, A. A., Ansari, M., Rechnitzer, C., Veal, G. J., Covezzoli, A., Brugières, L. & 4 othersPerilongo, G., Czauderna, P., Morland, B. & Neuwelt, E., Jun 21 2018, In : New England Journal of Medicine. 378, 25, p. 2376-2385 10 p.

Research output: Contribution to journalArticle

Hearing Loss
Cisplatin
Hepatoblastoma
Disease-Free Survival
Confidence Intervals